RNU6-426P

Across TCGA pan-cancer cohorts, RNU6-426P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNU6-426P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RNU6-426P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-426P expression acts as an unfavorable survival marker.

HNSC, UCEC, and BRCA are the cancer types where RNU6-426P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	All	0.413	0.752	<.001	129	view →
UCEC	DFS	Tertile	All	0.614	0.899	.001	78	view →
BRCA	DFS	Tertile	All	0.439	0.903	.014	60	view →
SARC	OS	Tertile	All	0.162	0.767	.002	18	view →
STAD	OS	Tertile	II,III,IV	0.271	0.720	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNU6-426P–HNSC (OS)

Open the HNSC breakdown →